LIVN Q3 2022 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$253M-0.2% YoY

Gross Profit

$171M67.7% margin

Operating Income

-$132M-52.2% margin

Net Income

-$107M-42.5% margin

EPS (Diluted)

$-2.01

QoQ Revenue Growth

-0.6%

Cash Flow

Operating Cash Flow

$36M

Free Cash Flow

$30M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$1.1B

Stockholders' Equity

$1.1B

Cash & Equivalents

$506M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$253M	$253M	-0.2%
Gross Profit	$171M	$169M	+1.3%
Operating Income	-$132M	$16M	-903.6%
Net Income	-$107M	-$43M	-147.1%

Revenue Segments

Neuromodulation Segment

$122M48%

Cardiopulmonary Segment

$121M48%

Advanced Circulatory Support Segment

$9M3%

Geographic Segments

UNITED STATES

$143M57%

Locations Excluding The United States And Europe

$69M27%

Europe

$40M16%